Home
/
IMPACT BIOMEDICAL INC.
/
Financials
/
Quarterly
IMPACT BIOMEDICAL INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IMPACT BIOMEDICAL INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$18.0K
Nov 7, 2025
Q2
2025
Jun 30, 2025
$7.0K
Aug 14, 2025
Q3
2023
Sep 30, 2022
$50.0K
Nov 13, 2023
Q2
2023
Jun 30, 2022
$50.0K
Oct 5, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.47M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($14.35M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.27M)
May 14, 2025
Q3
2025
Sep 30, 2024
$4.25M
Nov 7, 2025
Q2
2025
Jun 30, 2024
($889.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($962.0K)
May 14, 2025
Q3
2023
Sep 30, 2023
($1.18M)
Nov 13, 2023
Q2
2023
Jun 30, 2023
($1.12M)
Oct 5, 2023
Q1
2024
Mar 31, 2023
($849.0K)
May 10, 2024
Q3
2023
Sep 30, 2022
($2.24M)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($799.0K)
Oct 5, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($948.0K)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.15M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.01M)
May 14, 2025
Q3
2025
Sep 30, 2024
($1.13M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($626.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($771.0K)
May 14, 2025
Q3
2024
Sep 30, 2023
($1.08M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($1.01M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($803.0K)
May 10, 2024
Q3
2023
Sep 30, 2022
($889.0K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($750.0K)
Oct 5, 2023